European Countries Call For Health Technology Assessments Of COVID-19 Products
Value assessments of COVID-19 monoclonal antibodies should inform pricing decisions, says cross country coalition.
You may also be interested in...
EU health ministers are discussing booster and additional vaccines as well as COVID-19-related medicines shortages, and England is to offer approved vaccines to clinical trialists to ease international travel.
The UK has pipped the EU to the post in granting a marketing authorization to what the health secretary describes as “a significant addition to our armoury to tackle COVID-19.”
Brazil’s health technology assessment institute is to incorporate cost-effectiveness thresholds into its decision making.